Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02900495 · ClinicalTrials.gov registry record · NA
Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children
A NA study of Nocturnal Enuresis and Bedwetting, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
- 5
- Study locations
NCT02900495: Completed NA study of Nocturnal Enuresis and Bedwetting, sponsored by Northwell Health.
NCT02900495 is a NA study of Nocturnal Enuresis and Bedwetting that has completed, run by Northwell Health. The registered enrollment target is 147 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02900495, a NA study of Nocturnal Enuresis and Bedwetting, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
- 5
- Study locations
Study Summary
Children referred to the pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Patients who fail behavioral therapy and who meet inclusion criteria will be offered therapy with a TENS unit. Patients will be randomized into four groups. Group 1 will be the direct bladder stimulation arm with electrodes placed onto the abdomen in the suprapubic region directly over the bladder. Group 2 will be the distal neural loop arm with electrodes placed over the posterior tibial nerve. Group 3 will be the proximal neural loop arm with electrodes placed about 2-3 cm lateral to the midline in the sacral region at the level of S3. Group 4 will be the control arm with electrodes placed on the scapula. We will aim to recruit 32 patients per group for a total of 128 patients. The patients will be provided with a TENS unit (TENS 3000 Analog) and electrode pads and caretakers instructed on how to use the apparatus. The TENS sessions will be performed nightly before bed for 15 minutes. TENS units will be set at a frequency of 10 Hz, and intensity determined by the sensitivity threshold of the patient. Diaries including nighttime incontinence episodes and a "wet sheet" scale (dry, damp, wet, soaked) will be recorded, along with any adverse reactions to the TENS unit. Patients will be followed up after one month of TENS with evaluation including the Pediatric Urinary Incontinence Questionnaire, a validated tool for measuring quality of life in children with bladder dysfunction; this questionnaire will be filled out prior to starting TENS treatment in order to compare the effect of treatment on QOL. . They will then follow up on these parameters again after another month (one month off of TENS therapy) to assess the durability of treatment effect. The data will be collected at different time points (baseline, 1 month, 2 months) for each group by itself and the groups compared against each other using statistical analysis.
Primary Outcome
Total number of change in wet nights compared in each TENS arm to control and baseline wet nights
Conditions Studied
Interventions
- DEVICE transcutaneous electric nerve stimulation
Study Locations (5)
New York
- Albany Medical College - Albany
- Pediatric Urology Associates - Brooklyn
- Cohen Children's Medical Center of NY - New Hyde Park
- Pediatric Urology Associates - New Hyde Park
- Pediatric Urology Associates - Tarrytown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-09-15 |
| Phase | NA |
What the finished NCT02900495 record still lists
NCT02900495 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Nocturnal Enuresis appearing as the primary indexed condition, and to 1 intervention - of which transcutaneous electric nerve stimulation is the first listed.
NCT02900495 lists 5 locations in 1 state (New York).
Frequently Asked Questions
What is clinical trial NCT02900495 about?
NCT02900495 is a clinical study titled "Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children". Children referred to the pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Patients who fail behavioral therapy and who meet inclusion criteria will be offered therapy with a TENS unit. Patients will be randomized into four groups. Group 1 will be the direct b...
What is the current status of trial NCT02900495?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2016-08. Estimated completion is 2020-09-15.
What conditions does trial NCT02900495 study?
This clinical trial studies the following conditions: Nocturnal Enuresis, Bedwetting.
What interventions are being tested in trial NCT02900495?
The interventions under investigation include: transcutaneous electric nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT02900495?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02900495 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nocturnal Enuresis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02900495's enrollment target sits among peer trials
147 703rd of 2000 higher than 1,297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia